5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms [Yahoo! Finance]
Heron Therapeutics, Inc. (HRTX)
Last heron therapeutics, inc. earnings: 3/2 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
herontherapeutics.gcs-web.com/investor-home
Company Research
Source: Yahoo! Finance
Though pharmaceuticals have been exempted in the first round of reciprocal tariffs, they could well be Trump's target in the next round. Though the Trump administration has implemented a 90-day pause on all trading partners, excluding China, when imposed, tariffs on pharmaceutical imports can lead to potential disruptions to global supply chains and increased production costs. Biotech stocks have been under pressure ever since Trump appointed Robert F. Kennedy Jr., a well-known vaccine skeptic, as the new HHS secretary. The resignation of a key FDA regulator, Peter Marks, who supported faster FDA approval, reportedly ousted by RFK Jr,has also led to some concerns. However, amid all the headwinds, the Zacks Medical-Drugs industry is showing promising trends due to positive pipeline news and regulatory successes. In Trump's second innings, the biotech industry hopes to witness more innovation and mergers and acquisitions (M&A) activity. Innovation is at its peak for the industry, wi
Show less
Read more
Impact Snapshot
Event Time:
HRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HRTX alerts
High impacting Heron Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
HRTX
News
- Heron Therapeutics, Inc. (NASDAQ:HRTX) is favoured by institutional owners who hold 57% of the company [Yahoo! Finance]Yahoo! Finance
- Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)GlobeNewswire
- Heron Therapeutics: Stagnant Cash Cow, Blockbuster That Wasn't - Steer Clear [Seeking Alpha]Seeking Alpha
- Heron Therapeutics (NASDAQ:HRTX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..MarketBeat
- Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial ProgressGlobeNewswire
HRTX
Earnings
- 11/4/25 - Miss
HRTX
Sec Filings
- 11/26/25 - Form SCHEDULE
- 11/12/25 - Form 4
- 11/7/25 - Form 3
- HRTX's page on the SEC website